E/M Coding Alert - 2004 Issue 3
Managed Care: MEDICARE Rx BILL PUTS PBMs, HEALTH PLANS ON HOOK FOR COSTS
Subscribe or sign in to view the full article.
Article Overview
This article examines how the Medicare prescription drug benefit may affect managed care organizations, pharmacy benefit managers, and pharmaceutical manufacturers. It discusses the role of federal regulations, private plan negotiation, discount cards, and the broader cost pressures facing health plans as Medicare pharmacy coverage expands. The piece is relevant for managed care, pharmacy benefit management, and health policy audiences tracking Medicare implementation and drug-spending trends.
Why This Topic Matters
It helps readers understand the policy and operational context around Medicare Part D implementation, especially the shifting responsibilities for managing prescription-drug costs. Organizations involved in managed care, PBMs, and pharmaceutical contracting can use it to assess why the regulatory details matter and how the new benefit may influence plan expenses.
What You Will Learn
- How the Medicare prescription drug benefit could affect managed care and PBM relationships
- Why federal regulations are important to the law’s implementation
- What roles private health plans and PBMs may play in negotiating drug savings
- How discount cards and the upcoming full pharmacy benefit fit into the transition
- Why rising drug expenses remain a concern for health plans
Who Should Read This
- Managed care professionals
- Pharmacy benefit managers
- Health plan administrators
- Health policy analysts
- Payers and benefits managers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com